HomeProductsBuilding BlocksHeterocyclic ScaffoldsOxazolidinesZoliflodacin
Chemical structure of CAS 1620458-09-4

Zoliflodacin

CAS No.1620458-09-4
MDL No.N/A
MFC22H22FN5O7
MW487.40
InChI KeyZSWMIFNWDQEXDT-ZESJGQACSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1620458-09-4
Product NameZoliflodacin

Associated Conditions

gonorrhea
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Zoliflodacin: First Approval.

Drugs • Vol. 86, Issue 6 • 2026
PMID: 42002647DOI: 10.1007/s40265-026-02308-y

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

Lancet (London, England) • Vol. 407, Issue 10524 • 2026
PMID: 41391465PMC: PMC12784215DOI: 10.1016/S0140-6736(25)01953-1

Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects.

Clinical and translational science • Vol. 16, Issue 5 • 2023
PMID: 36824016PMC: PMC10176008DOI: 10.1111/cts.13487

Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates.

ACS infectious diseases • Vol. 6, Issue 6 • 2020
PMID: 32329999DOI: 10.1021/acsinfecdis.0c00021

Documentation